Why Everything You’ve Been Told About Alzheimer’s is Wrong (with Dale Bredesen MD)

The End of Alzheimer's: An Interview with Dr. Dale Bredesen Everything we thought we knew about Alzheimer’s is changing. In this episode, I sit down with Dr. Dale Bredesen to discuss his "36 holes in the roof" model, the latest clinical data on cognitive reversal, and how technologies like red light therapy and wearables are shaping the future of brain health. Timestamps 00:00 - Introduction to a New Paradigm 02:19 - From the Lab to Human Lives 03:15 - Supply vs. Demand: The Root of Decline 04:35 - The Truth About Amyloid 06:20 - The "36 Holes in the Roof" Analogy 08:50 - Personalizing the Protocol 12:15 - The Power of Early Detection 15:15 - Technology & Wearables in Brain Health 17:30 - The Four Phases of Alzheimer's 19:30 - Real Stories of Survival 23:00 - The Seven Basics of Brain Health 24:40 - Photobiomodulation & Red Light Therapy 29:45 - The APP Switch: Connection vs. Protection 41:35 - Expanding Beyond Alzheimer’s 46:11 - The Future of Healthcare Models 49:30 - Resources and Where to Learn More Resources & Links Free Cognitive Evaluation: mycqtest.com Advanced Blood Testing: getabrainscan.com Patient Support Community: APOE4.info Clinical Care: Pacific Neuroscience Institute Protocol Training & Info: Apollo Health Dr. Bredesen’s Books: The End of Alzheimer’s, The First Survivors of Alzheimer’s, and Ageless Brain 2025 RECODE Study Results The 2025 Randomized Controlled Trial (RCT) at six U.S. sites demonstrated that a personalized precision medicine approach is significantly more effective than the standard of care for early Alzheimer's and MCI. Cognitive Gains: Participants showed statistically significant improvements in memory, executive function, and processing speed. Effect Size: The ReCODE protocol showed an effect size 7 times greater than the amyloid-targeting drug lecanemab. Metabolic Health: Significant improvements were noted in blood pressure, insulin sensitivity (HbA1c), and inflammation markers. Preprint Study Link: Precision Medicine Treatment of Alzheimer’s Disease: Successful RCT (2025)